Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016 Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

New breast cancer initiative brings together pharma and Europe’s top researchers

February 9, 2016 Medical Communications, Research and Development Pfizer, breast cancer

The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …
News
aedes_aegypti_mosquito

INTERVIEW: Tackling the Zika threat

February 9, 2016 Manufacturing and Production, Medical Communications Zika, vaccines

The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …
Feature
uganda_health_minister_sarah_opendi_at_merck_uganda_cancer_day

Merck partners with Ugandan Health Ministry to tackle cancer awareness

February 8, 2016 Manufacturing and Production, Medical Communications Africa, Cancer, Merck

Germany’s Merck celebrated World Cancer Day by collaborating with the Uganda Ministry of Health to raise awareness about early detection …
News
jeremy_hunt_appears_on_thye_bbcs_andrew_marr_show_february_7

UK Health Secretary sets out £4.2 billion ‘digital NHS’ vision

February 8, 2016 Medical Communications, Sales and Marketing Jeremy Hunt, NHS

UK Health Secretary Jeremy Hunt has announced a £4.2 billion investment in the National Health Service (NHS) which will help …
News
Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016 Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …
News

Parliamentary committee says CDF must make better use of taxpayer money

February 5, 2016 Medical Communications Cancer Drugs Fund, Public Accounts Committee

The Cancer Drugs Fund, set up to improve patients’ access to cancer drugs, has not been managed effectively, a UK …
News
Lundbeck HQ

Lundbeck gets go-ahead for US and EU licence expansions

February 4, 2016 Medical Communications, Sales and Marketing Abilify, EMA, FDA, Lundbeck, Otsuka, Takeda, aripiprazole, brintellix, vortioxetine

Lundbeck has earned two recommendations from regulatory committees of the FDA and the EMA, which both recommended the company’s drugs …
News
Xarelto

Investigation questions Xarelto trial data accuracy

February 4, 2016 Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban

The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …
News
astrazeneca_plaque

AZ warns of patent losses as revenues fall

February 4, 2016 Medical Communications, Sales and Marketing AstraZeneca, Crestor, Zurampic

AstraZeneca announced full-year revenues down 7% to $24.7 billion, and Q4 sales down 5% to $6.4 billion, as the London-based …
News
rodger_currie

Rodger Currie to lead advocacy at US pharma trade body

February 3, 2016 Medical Communications PhRMA, Pharmaceutical Research and Manufacturers of America

Rodger Currie has joined the Pharmaceutical Research and Manufacturers of America (PhRMA) association as executive vice president for advocacy.He will lead federal, …
Appointment
merck_innovation_centre

Merck launches health tech start-up program in Africa

February 1, 2016 Manufacturing and Production, Medical Communications, Research and Development

Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
News
john_milligan_gilead_sciences

Gilead Sciences names John Milligan new CEO

January 29, 2016 Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan

Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Appointment
ABPI code

Regulation of drug promotion ‘should be toughened up’, study finds

January 29, 2016 Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion

The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …
News
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016 Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026